OM
Outset Medical, Inc.
$3.69
-21.05%
2026-05-08
About Outset Medical, Inc.
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Key Fundamentals
Forward P/E
-1.66
EPS (TTM)
$-5.37
ROE
-106.2%
Revenue Growth (YoY)
-2.0%
Profit Margin
-68.3%
Debt/Equity
79.75
Price/Book
0.56
Beta
1.91
Market Cap
$73.1M
Avg Volume (10D)
143K
Recent Breakout Signals
No recent breakout signals detected for OM.
Recent Price Range (60 Days)
60D High
$4.84
60D Low
$3.00
Avg Volume
190K
Latest Close
$3.69
Get breakout alerts for OM
Sign up for Breakout Scanner to receive daily notifications when OM triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Outset Medical, Inc. (OM) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors OM daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. OM operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.